TuHURA Biosciences, Inc. filed an 8-K on November 3, 2025, providing updates about its business operations and associated risk factors after completing mergers with Kineta, Inc. and Kintara Therapeutics, Inc. in the past year.
AI Assistant
TUHURA BIOSCIENCES INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.